Clinical Trial Update: Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of Zanzalintinib for advanced thyroid cancer is enrolling before surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neoadjuvant Treatment, Thyroid Cancer | Phase 2 | Status: RECRUITING